Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesityIlaria Barchetta, Flavia A Cimini, Caterina Chiappetta, et al.Journal of the Endocrine Society|December 22, 2017
WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 DiabetesIlaria Barchetta, Flavia Agata Cimini, Danila Capoccia, et al.International Journal of Molecular Sciences|December 2, 2020
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human ObesityValentina Ceccarelli, Ilaria Barchetta, Flavia Agata Cimini, et al.Diabetes/Metabolism Research and Reviews|May 30, 2020
Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver diseaseFlavia Agata Cimini, Ilaria Barchetta, Gea Ciccarelli, et al.Diabetes/Metabolism Research and Reviews|December 10, 2024
Circulating Proneurotensin Levels Predict Impaired Bone Mineralisation in Postmenopausal Women With Type 2 Diabetes MellitusIlaria Barchetta, Sara Dule, Flavia Agata Cimini, et al.Endocrine Research|August 15, 2020
Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up EvaluationFederica Sentinelli, Laura Bertoccini, Michela Incani, et al.BMC Medicine|June 30, 2016
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialIlaria Barchetta, Maria Del Ben, Francesco Angelico, et al.BMC Medicine|October 15, 2025
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trialIlaria Barchetta, Tiziana Filardi, Sara Dule, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 4, 2019
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesityFlavia Agata Cimini, Andrea Arena, Ilaria Barchetta, et al.Redox Biology|June 6, 2024
Biliverdin Reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3βChiara Lanzillotta, Antonella Tramutola, Simona Lanzillotta, et al.Pageof 7